Skip to main content
Clinical Trials/CTRI/2025/03/083091
CTRI/2025/03/083091Not yet recruitingNot Applicable

A clinical study to evaluate the efficacy of aamra pallava yoga in the management of Garbhini Chardi w.s.r emesis gravidarum

Dr Sahil Sanjay Jadhav1 site in 1 country60 target enrollmentStarted: March 31, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
To evaluate the efficacy of Amra pallava yoga in Garbhini chardi

Study Overview

Brief Summary

The present title ’A comparative clinical study to evaluate the efficacy of amrapallava Yoga In The Management Of Garbhini Chardi w.s.r emesis gravidarum ’ A clinical study of 60 registered pregnant women with their inclusion criteria and randomly alloted into 2 groups in each 30.

Group A will be administered with amrapallava Yoga 100mg BD with water

Group B will be administered with Tab Doxylamine succinate 10 mg 2 Hs.

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Participant Blinded

Eligibility Criteria

Ages
20.00 Year(s) to 35.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • Patients between ahe of 20-35 yrs age Patient diagnosed as Garbhini chardi in first trimester of pregnancy Both primi and multiparae.

Exclusion Criteria

  • Patients with hyper emesis gravidarum.
  • Patients in whom chardi seen in second and third trimester.
  • Patients with twin pregnancy, vesicular mole and ectopic pregnancy.
  • Vomiting caused due to systemic disorders like peptic ulcer, renal calculi, and appendicitis.

Outcomes

Primary Outcomes

To evaluate the efficacy of Amra pallava yoga in Garbhini chardi

Time Frame: 45 days or upto first trimester

Secondary Outcomes

  • To study in detail about garbhini chardi.(To study in detail about Emesis Gravidarum.)

Investigators

Sponsor
Dr Sahil Sanjay Jadhav
Sponsor Class
Other []

Study Sites (1)

Loading locations...

Similar Trials